Laura Laemmle-Weidenfeld appointed to the Board of Directors of the American Health Law Association

Laura Laemmle-Weidenfeld, a partner in the Health Care & Life Sciences Practice in the Washington Office, was recently appointed to the Board of Directors of the American Health Law Association (AHLA).

Ms. Weidenfeld defends a broad spectrum of health care providers, digital health entities, distributors, and pharmaceutical and medical device manufacturers against health care fraud enforcement actions brought by the U.S. Department of Justice (DOJ) and other federal and state agencies. She also helps clients conduct internal investigations and prepare and negotiate self-disclosures, and she provides clients with practical regulatory advice regarding compliance with federal and state health care fraud and abuse law. Earlier in her career, she led health care False Claims Act (FCA) investigations and litigation, including those brought under the FCA's qui tam (whistleblower) provisions, at the DOJ's Civil Division.

AHLA is the nation's largest, nonpartisan, 501(c)(3) educational organization devoted to legal issues in the healthcare field. Ms. Weidenfeld was chair of the AHLA's Fraud and Abuse Practice Group, 2014-2017; member, Planning Committee for the Fraud and Compliance Forum, 2021-2023, and is the author of Legal Issues in Health Care Fraud and Abuse, Fifth Edition, and its annual supplements, published by the AHLA.